Bank of New York Mellon’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $16.2M | Buy |
|
|||||
|
2025
Q2 | $2.22M | Buy |
|
|||||
|
2025
Q1 | $2.82M | Buy |
|
|||||
|
2024
Q4 | $2.96M | Buy |
|
|||||
|
2024
Q3 | $4.26M | Sell |
|
|||||
|
2024
Q2 | $5.99M | Buy |
|
|||||
|
2024
Q1 | $5.84M | Buy |
|
|||||
|
2023
Q4 | $4.99M | Buy |
|
|||||
|
2023
Q3 | $3.3M | Sell |
|
|||||
|
2023
Q2 | $4.92M | Buy |
|
|||||
|
2023
Q1 | $4.47M | Buy |
|
|||||
|
2022
Q4 | $4.9M | Buy |
|
|||||
|
2022
Q3 | $4.55M | Buy |
|
|||||
|
2022
Q2 | $3.22M | Sell |
|
|||||
|
2022
Q1 | $3.07M | Buy |
|
|||||
|
2021
Q4 | $3.65M | Sell |
|
|||||
|
2021
Q3 | $3.22M | Buy |
|
|||||
|
2021
Q2 | $2.52M | Buy |
|
|||||
|
2021
Q1 | $2.92M | Hold |
|
|||||
|
2020
Q4 | $2.9M | Buy |
|
|||||
|
2020
Q3 | $1.53M | Buy |
|
|||||
|
2020
Q2 | $1.53M | Buy |
|
|||||
|
2020
Q1 | $906K | Buy |
|
|||||
|
2019
Q4 | $658K | Buy |
|
|||||
|
2019
Q3 | $540K | Buy |
|
|||||
|
2019
Q2 | $659K | Buy |
|
|||||
|
2019
Q1 | $347K | Buy |
|
|||||
|
2018
Q4 | $289K | Buy |
|
|||||
|
2018
Q3 | $402K | Sell |
|
|||||
|
2018
Q2 | $564K | Buy |
|
|||||
|
2018
Q1 | $661K | Buy |
|
|||||
|
2017
Q4 | $396K | Sell |
|
|||||
|
2017
Q3 | $556K | Buy |
|
|||||
|
2017
Q2 | $615K | Buy |
|
|||||
|
2017
Q1 | $401K | Buy |
|
|||||
|
2016
Q4 | $146K | Buy |
|
|||||
|
2016
Q3 | $253K | Buy |
|